Gamma knife radiosurgery for trigeminal schwannomas

BACKGROUND: Trigeminal schwannomas are uncommon tumors that may be microsurgically removed in selected cases, albeit with significant risk for new neurological morbidity. We evaluated the role of stereotactic radiosurgery as an alternative for patients with newly diagnosed or residual trigeminal schwannomas. METHODS: The records of 23 patients who underwent radiosurgery for trigeminal schwannoma were reviewed. The most frequent presenting symptoms were facial numbness (11 patients), diplopia (6 patients), and facial pain (3 patients). One patient presented with partial complex seizures as the first symptom. Twelve patients had undergone one or more prior resections. Eleven underwent radiosurgery on the basis of imaging diagnosis only. The mean tumor volume was 4.5 mL (range 0.46-11.2 cc). Radiosurgery was performed using a median marginal dose of 15 Gy (range, 13-20 Gy). RESULTS: At a median imaging follow-up of 40 months (range, 12-146), 20 of 22 evaluable patients (91%) had tumor growth control (regression in 15 and no further tumor growth in 5). One 80-year-old patient died of unrelated cause 4 months after radiosurgery. Two patients with enlarged tumors were treated effectively with repeat radiosurgery. Twelve of 23 patients (52%) reported improvement and 9 (39%) had no change in their symptoms. Two patients noted new neurological complaints (transient facial weakness in 1 patient and worsening of the preradiosurgery facial numbness in another patient). CONCLUSIONS: Radiosurgery is an effective minimally invasive management option for patients with residual or newly diagnosed trigeminal schwannomas.